SPTBN2 and neurodegenerative disease: Mutations in βIII-spectrin are associated with a neurodegenerative disease that affects the cerebellar Purkinje cells (SCA5), and βIII-spectrin-deficient mice or mice expressing SCA5-mutant βIII-spectrin develop Purkinje cell degeneration.